Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
Completed
Conditions studied: Multiple Myeloma, Light Chain Nephropathy, Acute Kidney Injury
In brief
Objective 1: To test whether treatment with plasma exchange improves renal recovery in patients with light chain cast nephropathy Objective 2: To compare renal outcomes among patients treated with plasma exchange versus daratumumab-based regimens versus non-daratumumab based-regimens.
Key facts
- Study ID
- NCT06483139
- Run by
- Brigham and Women's Hospital
- People needed
- 549
- Starts
- 2024-06-01
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2026-07-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Brigham and Women's Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.